ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 148 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2020. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,407,000 | -17.5% | 192,695 | 0.0% | 0.08% | -19.0% |
| Q3 2021 | $6,550,000 | -74.5% | 192,695 | -69.4% | 0.10% | -74.1% |
| Q2 2021 | $25,705,000 | +1.5% | 629,100 | 0.0% | 0.39% | -4.9% |
| Q1 2021 | $25,328,000 | -24.7% | 629,100 | +10.5% | 0.41% | -28.8% |
| Q4 2020 | $33,651,000 | +21.0% | 569,100 | -0.5% | 0.57% | +4.6% |
| Q3 2020 | $27,816,000 | +192.6% | 571,990 | +191.1% | 0.54% | +183.9% |
| Q2 2020 | $9,507,000 | +72.7% | 196,500 | -0.8% | 0.19% | +46.6% |
| Q1 2020 | $5,504,000 | +80.5% | 198,120 | +94.3% | 0.13% | +142.6% |
| Q4 2019 | $3,050,000 | +71.3% | 101,950 | +76.9% | 0.05% | +68.8% |
| Q3 2019 | $1,781,000 | +5.4% | 57,630 | +64.7% | 0.03% | +6.7% |
| Q2 2019 | $1,690,000 | – | 35,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 15,115,090 | $419,897,000 | 10.74% |
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $30,986,000 | 10.41% |
| Robertson Stephens Wealth Management, LLC | 537,095 | $14,920,000 | 5.10% |
| VIKING GLOBAL INVESTORS LP | 33,493,708 | $930,455,000 | 4.84% |
| Senator Investment Group LP | 3,388,085 | $94,121,000 | 3.41% |
| Casdin Capital, LLC | 793,125 | $22,033,000 | 2.34% |
| Iron Triangle Partners LP | 150,000 | $4,167,000 | 1.61% |
| Aristotle Atlantic Partners, LLC | 370,841 | $10,302,000 | 1.57% |
| Crewe Advisors LLC | 93,000 | $2,584,000 | 1.54% |
| PERSONAL CFO SOLUTIONS, LLC | 112,916 | $3,137,000 | 1.13% |